Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Investments in related party investment funds, at fair value (cost - $441.9; 2020 - $891.9)	$ 909.6	$ 1,055.6
Debt securities, trading, at fair value (cost - $2,099.3; 2020 - $91.4)	2,085.6	101.3
Short-term investments, at fair value (cost - $1,076.0; 2020 - N/A)	1,075.8	0.0
Equity securities, trading, at fair value (cost - $4.5; 2020 - N/A)	2.8	0.0
Other long-term investments, at fair value (cost - $443.0; 2020 - $4.0) (includes related party investments at fair value of $258.2 (2020 - $4.0))	456.1	4.0
Total investments	4,529.9	1,160.9
Cash and cash equivalents	999.8	526.0
Restricted cash and cash equivalents	948.6	1,187.9
Redemption receivable from related party investment fund	250.0	0.0
Due from brokers	15.9	94.9
Interest and dividends receivable	8.3	0.9
Insurance and reinsurance balances receivable, net	1,708.2	441.9
Deferred acquisition costs and value of business acquired, net	218.8	68.6
Unearned premiums ceded	242.8	20.5
Loss and loss adjustment expenses recoverable, net	1,215.3	14.4
Deferred tax asset	182.0	0.4
Intangible assets	171.9	0.0
Other assets	126.8	18.8
Total assets	10,618.3	3,535.2
Liabilities
Loss and loss adjustment expense reserves	4,841.4	1,310.1
Unearned premium reserves	1,198.4	284.8
Reinsurance balances payable	688.3	78.1
Deposit liabilities	150.7	153.0
Securities sold, not yet purchased, at fair value	0.0	12.0
Due to brokers	6.5	0.0
Accounts payable, accrued expenses and other liabilities	229.8	17.6
Deferred tax liability	95.4	0.0
Liability-classified capital instruments	87.8	0.0
Debt	816.7	114.3
Total liabilities	8,115.0	1,969.9
Commitments and contingent liabilities
Shareholders’ equity
Common shares (issued and outstanding: 161,949,037; 2020 - 95,582,733)	16.2	9.6
Additional paid-in capital	1,622.7	933.9
Retained earnings	665.0	620.4
Accumulated other comprehensive loss	(0.2)	0.0
Shareholders’ equity attributable to SiriusPoint shareholders	2,503.7	1,563.9
Noncontrolling interests	(0.4)	1.4
Total shareholders’ equity	2,503.3	1,565.3
Total liabilities, noncontrolling interests and shareholders’ equity	10,618.3	3,535.2
Series B preference shares
Shareholders’ equity
Series B preference shares (par value $0.10; authorized and issued: 8,000,000)	$ 200.0	$ 0.0